Tsukuba, Japan

Masataka Harada



Average Co-Inventor Count = 5.0

ph-index = 3

Forward Citations = 16(Granted Patents)


Location History:

  • Ibaraki, JP (2007)
  • Tsukuba, JP (1998 - 2011)
  • Osaka, JP (2010 - 2011)

Company Filing History:


Years Active: 1998-2011

Loading Chart...
Loading Chart...
9 patents (USPTO):Explore Patents

Title: Masataka Harada: Innovator in Pharmaceutical Research

Introduction

Masataka Harada is a prominent inventor based in Tsukuba, Japan. He has made significant contributions to the field of pharmaceutical research, particularly in the development of compounds that have therapeutic applications in diabetes and other conditions. With a total of 9 patents to his name, Harada's work has had a notable impact on medical science.

Latest Patents

One of Harada's latest patents is the "Receptor function regulator," which involves a compound that includes an aromatic ring and a group capable of releasing cation. This invention is particularly useful as an insulin secretagogue or as an agent for the prophylaxis or treatment of diabetes. Another significant patent is related to "FPRL1 ligands and use thereof." This patent describes the use of FPRL1 ligand, which has a similar amino acid sequence to specific sequences, allowing for efficient screening of FPRL1 agonists or antagonists.

Career Highlights

Throughout his career, Masataka Harada has worked with notable companies in the pharmaceutical industry, including Takeda Pharmaceutical Company Limited and Takeda Chemical Industries, Inc. His work in these organizations has contributed to advancements in drug development and therapeutic solutions.

Collaborations

Harada has collaborated with esteemed colleagues such as Shuji Hinuma and Kazunori Nishi. These partnerships have fostered innovation and have been instrumental in the success of various research projects.

Conclusion

Masataka Harada's contributions to pharmaceutical research and his innovative patents highlight his role as a key figure in the field. His work continues to influence the development of new therapeutic agents, particularly in the treatment of diabetes and related conditions.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…